Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2009-7-14
pubmed:abstractText
Extensive experimental and neuropathological evidence supports the general hypothesis that decline in the basal forebrain cholinergic system contributes significantly to age-related cognitive impairment. Postmortem studies suggest reductions in neuronal nicotinic acetylcholine receptors (nAChRs, particularly the alpha(4)beta(2) subtype) with aging. This study aimed to determine the distribution of alpha(4)beta(2)-subtype nAChRs in vivo by 2-FA PET in healthy subjects (aged 21-83) and to establish whether there is an age-related decline in nAChRs. Furthermore, the relationship between PET measures of 2-FA binding and neurobehavioral measures of cognitive function was investigated. All participants were nonsmokers and underwent extensive cognitive testing and a PET scan after injection of 2-FA (200 MBq). Brain regional 2-FA binding was assessed through a simplified estimation of distribution volume (DV(S)). As expected, increasing age was associated with poorer cognitive performance, particularly on tasks assessing episodic memory and attentional processes. No significant age-related differences in regional nAChR DV(S) were found. Furthermore, no significant correlations were found between cognitive measures and nAChR DV(S). These results are consistent with recent studies suggesting the stability of cholinergic markers during senescence. It is plausible that changes in alpha(4)beta(2) nAChRs do occur with advancing age, but are beyond detection by the clinical 2-FA PET approach adopted here. However, this approach may be appropriate for use in pathologies considered to undergo extensive nAChR loss such as Alzheimer's disease and Parkinson's disease.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1098-2396
pubmed:author
pubmed:copyrightInfo
2009 Wiley-Liss, Inc.
pubmed:issnType
Electronic
pubmed:volume
63
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
752-63
pubmed:meshHeading
pubmed-meshheading:19484724-Acetylcholine, pubmed-meshheading:19484724-Adult, pubmed-meshheading:19484724-Aged, pubmed-meshheading:19484724-Aged, 80 and over, pubmed-meshheading:19484724-Aging, pubmed-meshheading:19484724-Azetidines, pubmed-meshheading:19484724-Binding, Competitive, pubmed-meshheading:19484724-Brain, pubmed-meshheading:19484724-Brain Mapping, pubmed-meshheading:19484724-Cognition Disorders, pubmed-meshheading:19484724-Female, pubmed-meshheading:19484724-Fluorine Radioisotopes, pubmed-meshheading:19484724-Humans, pubmed-meshheading:19484724-Male, pubmed-meshheading:19484724-Memory Disorders, pubmed-meshheading:19484724-Middle Aged, pubmed-meshheading:19484724-Neuropsychological Tests, pubmed-meshheading:19484724-Positron-Emission Tomography, pubmed-meshheading:19484724-Receptors, Nicotinic, pubmed-meshheading:19484724-Young Adult
pubmed:year
2009
pubmed:articleTitle
The relationship between nicotinic receptors and cognitive functioning in healthy aging: An in vivo positron emission tomography (PET) study with 2-[(18)F]fluoro-A-85380.
pubmed:affiliation
Monash University, Victoria, Australia. ellis@petnm.unimelb.edu.au
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't